Kimberly-Clark Corp. (KMB) Financial Statements
Historical financial data — 40 statements covering FY2016–FY2025
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes...
Kimberly-Clark Corp.'s revenue decreased 18.0% year over year, from $20.06B to $16.45B.
Net income decreased 20.6% over the same period, from $2.54B to $2.02B.
Over the 9-year period from FY2016 to FY2025, revenue declined by 10% in total.
Total debt remained relatively stable at $7.17B.
The debt-to-equity ratio stands at 4.77, indicating a high leverage profile.
Operating cash flow declined 14.1% to $2.78B.
Kimberly-Clark Corp. maintains a healthy net profit margin of 12.3%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $15.50B+50.5% | $1.25B | $5.29B | $1.67B | $2.33B | $17.15B | $8.09B | $680.0M |
| Q1 FY2024 | $5.10B-67.1% | $647.0M | $1.91B | $853.0M | $438.0M | $17.09B | $7.97B | $1.04B |
| Q2 FY2024 | $10.20B+100.0% | $1.19B | $3.72B | $1.51B | $1.46B | $17.28B | $7.96B | $1.14B |
| Q3 FY2024 | $15.13B+48.3% | $2.10B | $5.50B | $2.66B | $2.42B | $17.16B | $7.45B | $1.28B |
| Q1 FY2025 | $4.84B-68.0% | $567.0M | $1.73B | $769.0M | $327.0M | $16.30B | $7.25B | $1.10B |
| Q2 FY2025 | $8.22B+69.8% | $1.08B | $2.96B | $1.22B | $1.10B | $16.77B | $7.24B | $1.27B |
| Q3 FY2025 | $12.37B+50.5% | $1.52B | $4.46B | $1.84B | $1.80B | $16.89B | $7.30B | $1.33B |
| Q1 FY2026 | $4.16B-66.3% | $665.0M | $1.53B | $753.0M | $745.0M | $17.18B | $7.08B | $1.80B |
Balance Sheet Summary (Latest Period)
Total Assets
$17.10B
Total Liabilities
$15.60B
Total Equity
$1.50B
Cash & Equivalents
$688.0M
Total Debt
$7.17B
Current Assets
$5.31B
Current Liabilities
$7.13B
Retained Earnings
$9.61B